Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AT9283 |
| Trade Name | |
| Synonyms | AT-9283|AT 9283 |
| Drug Descriptions |
AT9283 is a dual inhibitor of JAK 2 and 3 kinases, Aurora kinases A and B, and has activity against Abl T315I (PMID: 19143567, PMID: 27905678). |
| DrugClasses | ABL1 Inhibitor 8 Aurka Inhibitors 27 Aurkb Inhibitors 21 JAK2 Inhibitor 19 JAK3 Inhibitor 6 |
| CAS Registry Number | 896466-04-9 |
| NCIT ID | C66947 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AT9283 | AT9283 | 0 | 0 |
| AT9283 + Vandetanib | AT9283 Vandetanib | 0 | 0 |